Literature DB >> 17380595

Adult hip dysplasia and osteoarthritis. Studies in radiology and clinical epidemiology.

Steffen Jacobsen1.   

Abstract

Osteoarthritis (OA) presupposes the interaction of systemic and/or local factors. In hip joint OA, congenital or developmental malformation is believed to constitute an individual risk factor for premature degeneration. Hip dysplasia (HD) is such a malformation. The radiological and epidemiological studies had several aims: To critically evaluate the radiological source material of the Copenhagen Heart Study: The Osteoarthritis Substudy, consisting of 4,151 standardized, weight bearing pelvic radiographs recorded 1991-1994. To qualify or disqualify the radiological source material for further studies. To develop a comprehensible and reproducible radiographic discriminator of hip OA with as close an association to self reported hip pain as possible. To identify prevalences of hip OA and HD in a Caucasian, urban background population and investigate the influence of sex, age, physical and occupational parameters on these prevalences. To evaluate the influence of HD on hip OA development relative to other potential risk factors. To evaluate degeneration in dysplastic hips over time. To evaluate the three dimensional anatomy of HD and the distribution of degenerative features in severely dysplastic hips, and To evaluate risk factors for total hip replacement surgery. In the course of the studies we found that assessments of classic indices of HD were significantly influenced by pelvic orientation during x-ray recording and identified exclusion limits of rotation and inclination/reclination of pelvic radiographs to stay inside a measurement error of +/- 3 degrees. We found that minimum joint space width (JSW) </= 2.mm constituted a radiologic hip OA discriminator of superior reproducibility and clinical relevance compared to composite, radiological OA classifications. We documented a progressive postmenopausal decline in female minimum JSW, while male minimum JSW remained relatively unaltered throughout life. We found no evidence that smoking, occupational exposure to repeated, heavy lifting or overweight significantly influenced minimum JSW. Prevalences of hip OA was approximately 5.5% in subjects >/= 60 years of age, and HD prevalence was 4-10%, depending on the radiographic criteria applied. Age and HD were significant risk factors for hip OA development in women, and HD was found to be a significant risk factor for hip OA in men. However, only obesity was found to determine an event of hip replacement surgery. In a longitudinal study of 81 subjects and with mild or moderate hip dysplasia followed for a decade we did not document a tendency for radiological degeneration compared to 136 control subjects. In a computerized tomographic study of severely dysplastic hips we found a close relationship between insufficient anterior, acetabular containment and proximal femoral anteversion. The primary area of degeneration in dysplastic hips was in the antero-lateral quadrant of the joint.

Entities:  

Mesh:

Year:  2006        PMID: 17380595

Source DB:  PubMed          Journal:  Acta Orthop Suppl        ISSN: 1745-3690


  28 in total

1.  Radiographic findings in restrained hip joints associated with ACL rupture.

Authors:  João L Ellera Gomes; Humberto Moreira Palma; Ricardo Becker
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2010-06-19       Impact factor: 4.342

2.  Apert syndrome: Be aware of the 'dodgy' hip!

Authors:  Shehzaad Aziz Khan; Thomas Steven Moores; Charles Docker
Journal:  BMJ Case Rep       Date:  2018-07-03

3.  Pattern of impact of femoroacetabular impingement upon health-related quality of life: the determinant role of extra-articular factors.

Authors:  Claudio Diaz-Ledezma; Paul M Lichstein; Mitchell Maltenfort; Camilo Restrepo; Javad Parvizi
Journal:  Qual Life Res       Date:  2013-02-08       Impact factor: 4.147

4.  [Total hip replacement in developmental dysplasia: anatomical features and technical pitfalls].

Authors:  B M Holzapfel; D Bürklein; F Greimel; U Nöth; M Hoberg; H Gollwitzer; M Rudert
Journal:  Orthopade       Date:  2011-06       Impact factor: 1.087

Review 5.  Routine 3D magnetic resonance imaging of joints.

Authors:  Richard Kijowski; Garry E Gold
Journal:  J Magn Reson Imaging       Date:  2011-04       Impact factor: 4.813

6.  Cranial acetabular retroversion is common in developmental dysplasia of the hip as assessed by the weight bearing position.

Authors:  Anders Troelsen; Lone Rømer; Steffen Jacobsen; Steen Ladelund; Kjeld Søballe
Journal:  Acta Orthop       Date:  2010-08       Impact factor: 3.717

7.  Hip pain and mobility deficits--hip osteoarthritis: clinical practice guidelines linked to the international classification of functioning, disability, and health from the orthopaedic section of the American Physical Therapy Association.

Authors:  Michael T Cibulka; Douglas M White; Judith Woehrle; Marcie Harris-Hayes; Keelan Enseki; Timothy L Fagerson; James Slover; Joseph J Godges
Journal:  J Orthop Sports Phys Ther       Date:  2009-04       Impact factor: 4.751

8.  Radiographic measurements of hip dysplasia at skeletal maturity--new reference intervals based on 2,038 19-year-old Norwegians.

Authors:  Lene Bjerke Laborie; Ingvild Øvstebø Engesæter; Trude Gundersen Lehmann; Francesco Sera; Carol Dezateux; Lars Birger Engesæter; Karen Rosendahl
Journal:  Skeletal Radiol       Date:  2013-01-27       Impact factor: 2.199

9.  Regional variations in MR relaxation of hip joint cartilage in subjects with and without femoralacetabular impingement.

Authors:  Karupppasamy Subburaj; Alexander Valentinitsch; Alexander B Dillon; Gabby B Joseph; Xiaojuan Li; Thomas M Link; Thomas P Vail; Sharmila Majumdar
Journal:  Magn Reson Imaging       Date:  2013-05-16       Impact factor: 2.546

10.  Weightbearing anteroposterior pelvic radiographs are recommended in DDH assessment.

Authors:  Anders Troelsen; Steffen Jacobsen; Lone Rømer; Kjeld Søballe
Journal:  Clin Orthop Relat Res       Date:  2008-03-12       Impact factor: 4.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.